Neagoe Oana, Ciobanu Anda, Diaconu Rodica, Mirea Oana, Donoiu Ionuț, Militaru Constantin
Department of Cardiology, Emergency County Hospital, Craiova, Romania.
Department of Cardiology, University of Medicine and Pharmacy of Craiova, Romania.
Discoveries (Craiova). 2019 Sep 30;7(3):e99. doi: 10.15190/d.2019.12.
Restrictive cardiomyopathy is the least common type of cardiomyopathy, being defined by diastolic dysfunction and often unimpaired systolic function. Restrictive cardiomyopathies can be classified as familial or non-familial. Patients with familial restrictive cardiomyopathy can develop signs and symptoms of this condition anytime from childhood to adulthood. The evolution of the disease is towards signs and symptoms of pulmonary and systemic congestion and, without treatment, there is a five-year mortality rate of approximately 30% in these patients. We discuss the case of a 43-year-old patient diagnosed with familial restrictive cardiomyopathy with positive genetic tests for mutations of MYH7 gene and ABCC9 gene, who was first hospitalized in 2011 for palpitations. The echocardiography performed in evolution showed a continuous alteration of right ventricle function, without important differences of left ventricular function. She developed heart failure symptoms six years after diagnosis and she had seven hospitalizations in the past two years, currently with an increasing need of diuretics and persistent hepatic dysfunction. Cardiac transplantation or left ventricular assist device therapy should be considered in patients with severe heart failure symptoms and no longer effective treatment. However, elevated pulmonary vascular resistance excludes the patient from cardiac transplantation.
限制型心肌病是心肌病中最不常见的类型,其定义为舒张功能障碍,而收缩功能通常未受损害。限制型心肌病可分为家族性或非家族性。家族性限制型心肌病患者从儿童期到成年期的任何时候都可能出现该病的体征和症状。疾病的发展趋势是出现肺和体循环淤血的体征和症状,未经治疗的情况下,这些患者的五年死亡率约为30%。我们讨论了一例43岁被诊断为家族性限制型心肌病的患者,其MYH7基因和ABCC9基因的突变基因检测呈阳性,该患者于2011年因心悸首次住院。病情发展过程中进行的超声心动图检查显示右心室功能持续改变,左心室功能无明显差异。她在确诊六年后出现心力衰竭症状,在过去两年中住院七次,目前对利尿剂的需求不断增加且肝功能持续异常。对于有严重心力衰竭症状且治疗不再有效的患者,应考虑心脏移植或左心室辅助装置治疗。然而,肺血管阻力升高使该患者不符合心脏移植条件。